본문 바로가기
KERD
논문KCI 등재

Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Neurological diseases such as Alzheimer, Parkinson, and ischemic stroke have increased in occurrence and become important health issues throughout the world. There is currently no effective therapeutic strategy for addressing neurological deficits after the development of these major neurological disorders. In recent years, it has become accepted that adult neural stem cells located in the subventricular and subgranular zones have the ability to proliferate and differentiate in order to replace lost or damaged neural cells. There have been many limitations in the clinical application of both endogenous and exogenous neurogenesis for neurological disorders. However, many studies have investigated novel mechanisms in neurogenesis and have shown that these limitations can potentially be overcome with appropriate stimulation and various approaches. We will review concepts related to possible therapeutic strategies focused on the perspective of neurogenesis for the treatment of patients diagnosed with Alzheimer disease, Parkinson disease, and ischemic stroke based on current reports.

Abstract

Neurological diseases such as Alzheimer, Parkinson, and ischemic stroke have increased in occurrence and become important health issues throughout the world. There is currently no effective therapeutic strategy for addressing neurological deficits after the development of these major neurological disorders. In recent years, it has become accepted that adult neural stem cells located in the subventricular and subgranular zones have the ability to proliferate and differentiate in order to replace lost or damaged neural cells. There have been many limitations in the clinical application of both endogenous and exogenous neurogenesis for neurological disorders. However, many studies have investigated novel mechanisms in neurogenesis and have shown that these limitations can potentially be overcome with appropriate stimulation and various approaches. We will review concepts related to possible therapeutic strategies focused on the perspective of neurogenesis for the treatment of patients diagnosed with Alzheimer disease, Parkinson disease, and ischemic stroke based on current reports.

참고문헌 (100)

  1. 최동영, "Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer’s disease, Parkinson’s disease and ischemic brain stroke: their molecular targets and action mechanisms", Archives of Pharmacal Research, 38(2), pp.139~170 (2015), 대한약학회
  2. Mu Y, "Adult hippocampal neurogenesis and its role in Alzheimer’s disease", Mol Neurodegener, 6, pp.85~ (2011)
  3. Ono M, "Highly selective tau-SPECT imaging probes for detection of neurofibrillary tangles in Alzheimer’s disease", Sci Rep, 6, pp.34197~ (2016)
  4. Zhang L, "Targeted methylation sequencing reveals dysregulated Wnt signaling in Parkinson disease", J Genet Genomics, 43, pp.587~592 (2016)
  5. Marxreiter F, "Adult neurogenesis in Parkinson’s disease", Cell Mol Life Sci, 70, pp.459~473 (2013)
  6. Seong-Ho Koh, "Neurogenesis in Stroke Recovery", Translational Stroke Research (2016), Springer Nature[DOI]
  7. Ming GL, "Adult neurogenesis in the mammalian brain: significant answers and significant questions", Neuron, 70, pp.687~702 (2011)
  8. Alvarez-Buylla A, "For the long run: maintaining germinal niches in the adult brain", Neuron, 41, pp.683~686 (2004)
  9. Gage FH, "Mammalian neural stem cells", Science, 287, pp.1433~1438 (2000)
  10. Luskin MB, "Neuronal progenitor cells derived from the anterior subventricular zone of the neonatal rat forebrain continue to proliferate in vitro and express a neuronal phenotype", Mol Cell Neurosci, 8, pp.351~366 (1997)
  11. Huttner WB, "Stem cells: slow and steady wins the race", Nat Neurosci, 18, pp.613~614 (2015)
  12. Altman J, "Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats", J Comp Neurol, 124, pp.319~335 (1965)
  13. Temple S, "Division and differentiation of isolated CNS blast cells in microculture", Nature, 340, pp.471~473 (1989)
  14. Bayer SA, "Development of the hippocampal region in the rat. I. Neurogenesis examined with 3H-thymidine autoradiography", J Comp Neurol, 190, pp.87~114 (1980)
  15. Marna Eliana Sakalem, "Environmental enrichment and physical exercise revert behavioral and electrophysiological impairments caused by reduced adult neurogenesis", Hippocampus, 27(1), pp.36~51 (2016), Wiley-Blackwell[DOI]
  16. Reynolds BA, "Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system", Science, 255, pp.1707~1710 (1992)
  17. Yoo DY, "Glucose metabolism and neurogenesis in the gerbil hippocampus after transient forebrain ischemia", Neural Regen Res, 11, pp.1254~1259 (2016)
  18. Capilla-Gonzalez V, "The aged brain: genesis and fate of residual progenitor cells in the subventricular zone", Front Cell Neurosci, 9, pp.365~ (2015)
  19. Luo L, "Axon retraction and degeneration in development and disease", Annu Rev Neurosci, 28, pp.127~156 (2005)
  20. Imitola J, "Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha", CXC chemokine receptor 4 pathway, 2004, pp.101, 18117~18122
  21. Li Y, "Postacute stromal cell-derived factor-1α expression promotes neurovascular recovery in ischemic mice", Stroke, 45, pp.1822~1829 (2014)
  22. Yu DX, "Modeling hippocampal neurogenesis using human pluripotent stem cells", Stem Cell Reports, 2, pp.295~310 (2014)
  23. Encinas JM, "Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus", Cell Stem Cell, 8, pp.566~579 (2011)
  24. Zhang P, "Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe", PSEN1 mice, 2015, pp.290, 214~226
  25. Gonzalez FF, "Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke", Stroke, 44, pp.753~758 (2013)
  26. Abeysinghe HC, "Pre-differentiation of human neural stem cells into GABAergic neurons prior to transplant results in greater repopulation of the damaged brain and accelerates functional recovery after transient ischemic stroke", Stem Cell Res Ther, 6, pp.186~ (2015)
  27. Chen P, "Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer’s disease", Gene, 587, pp.59~63 (2016)
  28. Wei L, "Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats", Neurobiol Dis, 46, pp.635~645 (2012)
  29. Duarte-Neves J, "Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases", Neurobiol Dis, 95, pp.210~224 (2016)
  30. Winner B, "Adult neurogenesis in neurodegenerative diseases", Cold Spring Harb Perspect Biol, 7, pp.a021287~ (2015)
  31. Crews L, "APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis", Brain Struct Funct, 214, pp.111~126 (2010)
  32. Sherrington R, "Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease", Nature, 375, pp.754~760 (1995)
  33. Rogaev EI, "Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene", Nature, 376, pp.775~778 (1995)
  34. Goate A, "Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease", Nature, 349, pp.704~706 (1991)
  35. Rodríguez JJ, "Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer’s disease", PLoS One, 3, pp.e2935~ (2008)
  36. Sun B, "Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer’s disease", Cell Stem Cell, 5, pp.624~633 (2009)
  37. Blain JF, "Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease", Alzheimers Res Ther, 8, pp.34~ (2016)
  38. Bursavich MG, "Gamma secretase modulators: new Alzheimer’s drugs on the horizon?", J Med Chem, 59, pp.7389~7409 (2016)
  39. Doody RS, "A phase 3 trial of semagacestat for treatment of Alzheimer’s disease", N Engl J Med, 369, pp.341~350 (2013)
  40. De Strooper B, "Lessons from a failed γ-secretase Alzheimer trial", Cell, 159, pp.721~726 (2014)
  41. Coric V, "Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease", Arch Neurol, 69, pp.1430~1440 (2012)
  42. Weggen S, "A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity", Nature, 414, pp.212~216 (2001)
  43. Oehlrich D, "Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators", Bioorg Med Chem Lett, 23, pp.4794~4800 (2013)
  44. Adeosun SO, "Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction", J Biol Chem, 289, pp.2946~2959 (2014)
  45. Chen HK, "Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease", J Biol Chem, 286, pp.5215~5221 (2011)
  46. Mahley RW, "Apolipoprotein E4:a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease", Proc Natl Acad Sci U S A, 103, pp.5644~5651 (2006)
  47. Li G, "GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4knockin mice", Cell Stem Cell, 5, pp.634~645 (2009)
  48. Kim JY, "Application of human umbilical cord blood-derived mesenchymal stem cells in disease models", World J Stem Cells, 2, pp.34~38 (2010)
  49. Hsieh JY, "Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis", PLoS One, 8, pp.e72604~ (2013)
  50. Kim DH, "GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer’s disease model", Stem Cells Dev, 24, pp.2378~2390 (2015)
  51. Qi Zhang, "Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer's disease", Journal of Neurochemistry, 136(4), pp.815~825 (2016), Wiley-Blackwell[DOI]
  52. Biallosterski BT, "Changes in voiding behavior in a mouse model of Alzheimer’s disease", Front Aging Neurosci, 7, pp.160~ (2015)
  53. Andersson E, "Identification of intrinsic determinants of midbrain dopamine neurons", Cell, 124, pp.393~405 (2006)
  54. Ono Y, "Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells", Development, 134, pp.3213~3225 (2007)
  55. Deng Q, "Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development", Development, 138, pp.3399~3408 (2011)
  56. Yan CH, "Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors", J Neurosci, 31, pp.12413~12425 (2011)
  57. Kim CH, "Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease", Proc Natl Acad Sci U S A, 112, pp.8756~8761 (2015)
  58. Hedlund E, "Dopamine receptor antagonists enhance proliferation and neurogenesis of midbrain Lmx1a-expressing progenitors", Sci Rep, 6, pp.26448~ (2016)
  59. Chandra S, "Double-knockout mice for alpha- and beta-synucleins:effect on synaptic functions", Proc Natl Acad Sci U S A, 101, pp.14966~14971 (2004)
  60. Winner B, "Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus", J Neurosci, 32, pp.16906~16916 (2012)
  61. Kohl Z, "Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson’s disease", Neurobiol Dis, 85, pp.206~217 (2016)
  62. Cookson MR, "The role of leucine-rich repeat kinase 2(LRRK2) in Parkinson’s disease", Nat Rev Neurosci, 11, pp.791~797 (2010)
  63. Liu GH, "Progressive degeneration of human neural stem cells caused by pathogenic LRRK2", Nature, 491, pp.603~607 (2012)
  64. Schwab AJ, "Neurite aggregation and calcium dysfunction in iPSC-derived sensory neurons with Parkinson’s disease-related LRRK2 G2019S mutation", Stem Cell Reports, 5, pp.1039~1052 (2015)
  65. Sánchez-Danés A, "Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease", EMBO Mol Med, 4, pp.380~395 (2012)
  66. Ramonet D, "Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2", PLoS One, 6, pp.e18568~ (2011)
  67. Cooper O, "Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease", Sci Transl Med, 4, pp.141ra90~ (2012)
  68. Weng YH, "(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model", Exp Neurol, 275(Pt 1), pp.104~115 (2016)
  69. Wider C, "Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation", Neurodegener Dis, 7, pp.175~179 (2010)
  70. Taymans JM, "Mechanisms in dominant parkinsonism:The toxic triangle of LRRK2, alpha-synuclein, and tau", Bioessays, 32, pp.227~235 (2010)
  71. Han F, "Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson’s disease", Cytotherapy, 17, pp.665~679 (2015)
  72. Yu J, "Human induced pluripotent stem cells free of vector and transgene sequences", Science, 324, pp.797~801 (2009)
  73. Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
  74. Blanco L, "Functional role of Barrington’s nucleus in the micturition reflex: relevance in the surgical treatment of Parkinson’s disease", Neuroscience, 266, pp.150~161 (2014)
  75. Campeau L, "Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease", J Urol, 191, pp.850~859 (2014)
  76. Zhang R, "Function of neural stem cells in ischemic brain repair processes", J Cereb Blood Flow Metab, 36, pp.2034~2043 (2016)
  77. Minger SL, "Endogenous neurogenesis in the human brain following cerebral infarction", Regen Med, 2, pp.69~74 (2007)
  78. Jin K, "Evidence for stroke-induced neurogenesis in the human brain", Proc Natl Acad Sci U S A, 103, pp.13198~13202 (2006)
  79. Macas J, "Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain", J Neurosci, 26, pp.13114~13119 (2006)
  80. Jin K, "Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat", Proc Natl Acad Sci U S A, 98, pp.4710~4715 (2001)
  81. Arvidsson A, "Neuronal replacement from endogenous precursors in the adult brain after stroke", Nat Med, 8, pp.963~970 (2002)
  82. Zhang RL, "Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia", Neuroscience, 105, pp.33~41 (2001)
  83. Parent JM, "Rat forebrain neurogenesis and striatal neuron replacement after focal stroke", Ann Neurol, 52, pp.802~813 (2002)
  84. Olle Lindvall, "Neurogenesis following Stroke Affecting the Adult Brain", Cold Spring Harbor Perspectives in Biology, 7(11), pp.a019034~ (2015), Cold Spring Harbor Laboratory[DOI]
  85. Nakayama D, "Injury-induced neural stem", progenitor cells in post-stroke human cerebral cortex, 2010, pp.31, 90~98
  86. Huttner HB, "The age and genomic integrity of neurons after cortical stroke in humans", Nat Neurosci, 17, pp.801~803 (2014)
  87. Love S, "Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain", Nat Med, 11, pp.703~704 (2005)
  88. Kobayashi T, "Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats", Stroke, 37, pp.2361~2367 (2006)
  89. Sofroniew MV, "Nerve growth factor signaling, neuroprotection, and neural repair", Annu Rev Neurosci, 24, pp.1217~1281 (2001)
  90. Li WJ, "Treatment with UDP-glucose, GDNF, and memantine promotes SVZ and white matter self-repair by endogenous glial progenitor cells in neonatal rats with ischemic PVL", Neuroscience, 284, pp.444~458 (2015)
  91. 고성호, "Te Role of the PI3K Pathway in the Regeneration of the Damaged Brain by Neural Stem Cells afer Cerebral Infarction", Journal of Clinical Neurology, 11(4), pp.297~304 (2015), 대한신경과학회[DOI]
  92. Tang G, "A natural diarylheptanoid promotes neuronal differentiation via activating ERK and PI3K-Akt dependent pathways", Neuroscience, 303, pp.389~401 (2015)
  93. Tiwari SK, "Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an amyloid-β Toxin-induced Alzheimer rat model via the phosphatidylinositol 3-kinase (PI3K)", Akt, β-catenin pathway, pp.J Biol Chem, 2015[DOI]
  94. Kong X, "Tetramethylpyrazine promotes migration of neural precursor cells via activating the phosphatidylinositol 3-kinase pathway", Mol Neurobiol, 53, pp.6526~6539 (2016)
  95. Bokara KK, "Transfection of arginine decarboxylase gene increases the neuronal differentiation of neural progenitor cells", Stem Cell Res, 17, pp.256~265 (2016)
  96. Jin K, "Effect of human neural precursor cell transplantation on endogenous neurogenesis after focal cerebral ischemia in the rat", Brain Res, 1374, pp.56~62 (2011)
  97. Mine Y, "Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats", Neurobiol Dis, 52, pp.191~203 (2013)
  98. Zhang P, "Human embryonic neural stem cell transplantation increases subventricular zone cell proliferation and promotes peri-infarct angiogenesis after focal cerebral ischemia", Neuropathology, 31, pp.384~391 (2011)
  99. Cho YS, "A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction:Analysis of lower urinary tract function", Mol Med Rep, 12, pp.2563~2569 (2015)
  100. Miyazato M, "Effects of duloxetine on urethral continence reflex and bladder activity in rats with cerebral infarction", J Urol, 194, pp.842~847 (2015)

관련 논문AI추천

이 간행물의 다른 논문 (21건)